Furthermore, analyzing data from the GENT2 database, we observed that the expression of C1QL1 was lower in HER2-positive BrCa compared with HER2-negative (triple negative and luminal) BrCa tissues. The gene discussed is ERBB2; the disease is invasive breast carcinoma.